Detalhe da pesquisa
1.
Case Report: Safety and Efficacy of Omalizumab in a 13-Year-Old Patient With Chronic Spontaneous Urticaria and Type 1 Diabetes.
Front Immunol
; 13: 853561, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35493474
2.
Prolonged asymptomatic SARS-CoV-2 infection in a child receiving immunosuppressive therapy.
Pediatr Pulmonol
; 55(10): 2504-2505, 2020 10.
Artigo
Inglês
| MEDLINE | ID: mdl-32735761